Nvidia and Roche Group’s Genentech have announced a multi-year strategic collaboration to advance AI research in drug discovery and expedite the delivery of novel therapies to patients. Through this partnership, Genentech will combine its own models and datasets with Nvidia’s AI computing stack to leverage generative AI. Nvidia’s DGX Cloud and BioNemo offerings will play a key role in this collaboration.
Related Posts
Exploring the Challenges and Opportunities of AI Adoption
Exploring the Challenges and Opportunities of AI Adoption Presented by Outshift by Cisco The Growing Pressure to Deploy…
GenAI’s Impact on the Semiconductor Industry
Reviving the Semiconductor Industry After experiencing five consecutive quarters of declining revenue, the semiconductor industry has made a…
Exploring OpenAI’s Collective Alignment Team: A Step Towards Democratic AI Governance
Last week, OpenAI announced the formation of their new “Collective Alignment” team, dedicated to prototyping processes that incorporate…
Nanome Launches MARA: AI Copilot for Scientists in Virtual Reality
San Diego-based Nanome, a startup that allows scientists to understand 3D molecular structures in virtual reality, has announced…